Stock Events

Stock Events

Clinuvel Pharmaceuticals (CUV.AU) Q3 2024 Earnings

28AugConfirmed

Q1 2023

Q3 2023

Q1 2024

Q3 2024

0.21

0.3

0.39

0.49

Details

Expected EPS

0.43279143762434596

Actual EPS

0.48530012526711364

Surprise EPS

0.05

Surprise Percent

+12.13%

Description

Clinuvel Pharmaceuticals (CUV.AU) has reported earnings of 0.48530012526711364 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.